Skip to content

Insider · CIK 0001507496

Thomas Andrew Rowland

officer

Files at ANIP (ANI PHARMACEUTICALS INC). First filing Aug 14, 2025, latest Aug 14, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $426k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ANIP: ANI PHARMACEUTICALS INC

ANIPOct 9, 2026 · close 73.89

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
52Moderate
ANIPsell 13
ANI PHARMACEUTICALS INC
$426k
4,975 shares
-11%+66% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 12, 2025ANIP
ANI PHARMACEUTICALS INC
SOpen-market sale
Common Stock
-4,975$85.71$426k40,794Aug 14, 2025
Feb 28, 2025ANIP
ANI PHARMACEUTICALS INC
FTax withholding
Common Stock
-627$61.89$39k45,465Mar 4, 2025
Feb 12, 2025ANIP
ANI PHARMACEUTICALS INC
AGrant or award
Common Stock
+7,834$0.00$041,452Feb 18, 2025
Feb 12, 2025ANIP
ANI PHARMACEUTICALS INC
AGrant or award
Common Stock
+5,222$0.00$046,674Feb 18, 2025
Feb 14, 2025ANIP
ANI PHARMACEUTICALS INC
FTax withholding
Common Stock
-582$58.92$34k46,092Feb 18, 2025
Nov 15, 2024ANIP
ANI PHARMACEUTICALS INC
FTax withholding
Common Stock
-867$56.58$49k33,169Nov 18, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Thomas Andrew Rowland: insider trades and track record | InsiderTell